Bellan, M.; Giubertoni, A.; Piccinino, C.; Buffa, M.; Cromi, D.; Sola, D.; Pedrazzoli, R.; Gagliardi, I.; Calzaducca, E.; Zecca, E.;
et al. Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases. Pharmaceuticals 2021, 14, 342.
https://doi.org/10.3390/ph14040342
AMA Style
Bellan M, Giubertoni A, Piccinino C, Buffa M, Cromi D, Sola D, Pedrazzoli R, Gagliardi I, Calzaducca E, Zecca E,
et al. Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases. Pharmaceuticals. 2021; 14(4):342.
https://doi.org/10.3390/ph14040342
Chicago/Turabian Style
Bellan, Mattia, Ailia Giubertoni, Cristina Piccinino, Mariachiara Buffa, Debora Cromi, Daniele Sola, Roberta Pedrazzoli, Ileana Gagliardi, Elisa Calzaducca, Erika Zecca,
and et al. 2021. "Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases" Pharmaceuticals 14, no. 4: 342.
https://doi.org/10.3390/ph14040342
APA Style
Bellan, M., Giubertoni, A., Piccinino, C., Buffa, M., Cromi, D., Sola, D., Pedrazzoli, R., Gagliardi, I., Calzaducca, E., Zecca, E., Patrucco, F., Patti, G., Sainaghi, P. P., & Pirisi, M.
(2021). Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases. Pharmaceuticals, 14(4), 342.
https://doi.org/10.3390/ph14040342